November 20, 2013
Pfizer's Biosimilar Unit General Manager Diem Nguyen American drug maker Pfizer Inc. is eyeing to enter the Japanese biosimilar market with a plan to simultaneously and globally file for approvals of biosimilar versions of five products including the rheumatoid arthritis...read more